Peptide Research · 7 min read

GH, GHRH, and GHRP: Understanding the Somatotropic Axis

The somatotropic axis is the neuroendocrine system responsible for the production, regulation, and downstream actions of growth hormone (GH). Distinguishing between GH, growth hormone-releasing hormone (GHRH), and growth hormone-releasing peptides (GHRPs) is essential for researchers investigating this hormonal cascade and the peptides that interact with it.

Growth hormone is a 191-amino acid single-chain polypeptide produced by somatotroph cells of the anterior pituitary. Its release follows a characteristic pulsatile rhythm, with the most prominent secretory episodes occurring during deep slow-wave sleep. GH acts both directly on target tissues and indirectly via insulin-like growth factor 1 (IGF-1), which is synthesized predominantly by the liver in response to GH receptor activation.

GHRH is a 44-amino acid peptide hormone originating in the hypothalamus, with the first 29 residues constituting its minimal bioactive core. It engages the GHRH receptor (GHRH-R) on pituitary somatotrophs, triggering adenylate cyclase activation and a rise in intracellular cAMP that ultimately drives GH gene transcription and hormone release.

Each MyPeptide reference page is organized around product identity, documentation, and research context rather than medical claims, dosing instructions, or personal-use outcomes.

Use the related links on this page to move between the catalog, COA records, policy pages, and supporting research guides while staying within the research-use-only scope.

Batch documentation, product identity, and compliance context are kept close together so qualified purchasers can review the material before continuing through the storefront.